About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
BOARD MEETINGS
Board
Meetings
Vikas Lifecare Ltd.
From Date
:
To Date
:
Source Date
Board Meeting Date
Details
07-Aug-2025
14-Aug-2025
Quarterly Results
26-May-2025
28-May-2025
Audited Results
10-Feb-2025
14-Feb-2025
Quarterly Results
17-Dec-2024
20-Dec-2024
Inter-alia, to consider issuance of securities, in order to further augment the long-term resources of the Company, subject to all statutory approvals, and to appoint intermediaries for this purpose and to amend the Capital Clause of the Memorandum of the Company;
16-Oct-2024
22-Oct-2024
Quarterly Results
18-Jul-2024
20-Jul-2024
Quarterly Results
13-May-2024
29-May-2024
Audited Results
07-Feb-2024
13-Feb-2024
Quarterly Results
11-Oct-2023
17-Oct-2023
Quarterly Results
04-Sep-2023
06-Sep-2023
Preferential Issue of shares
28-Aug-2023
31-Aug-2023
Preferential Issue of shares
04-Aug-2023
12-Aug-2023
Quarterly Results
11-May-2023
23-May-2023
Increase in Authorised Capital (Revised) & Audited Results The Board Meeting to be held on 19/05/2023 has been revised to 23/05/2023 The Board Meeting to be held on 19/05/2023 has been revised to 23/05/2023
08-May-2023
19-May-2023
Audited Results
19-Jan-2023
25-Jan-2023
Quarterly Results & Inter alia,to consider, review and evaluate the progress in various businesses, strategies and their recent developments, and to consider and evaluate certain new business opportunities which could advantageously be combined with the Company's existing line of business and competencies, and all other matters connected therewith and incidental thereto.
13-Oct-2022
21-Oct-2022
Quarterly Results
01-Sep-2022
03-Sep-2022
A.G.M.
18-Jul-2022
25-Jul-2022
Quarterly Results
20-May-2022
28-May-2022
Audited Results
11-Feb-2022
15-Feb-2022
General Purpose
Page
1
of
2
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.